University of Virginia launches collaboratory on data, AI, and health
Business Announcement
This month, we’re focusing on artificial intelligence (AI), a topic that continues to capture attention everywhere. Here, you’ll find the latest research news, insights, and discoveries shaping how AI is being developed and used across the world.
Updates every hour. Last Updated: 1-May-2026 11:16 ET (1-May-2026 15:16 GMT/UTC)
The energy transition is intensifying the challenges for grid control due to increased fluctuations in electricity generation and consumption. Modern AI systems could support professionals working in grid control centres in their daily tasks, helping to make critical infrastructure more resilient in the face of unforeseen events. A German junior research group is developing an AI-supported software system that can learn, is reliable and transparent in its decision-making.
According to the agreement, Insilico Medicine will utilize its proprietary Pharma.AI platform to focus on the design and optimization of novel small molecules for treating metabolic diseases, while Qilu Pharmaceutical Group will be responsible for subsequent development and commercialization procedures. The total contract value approaches $120 million, including development and commercialization milestone payments, as well as single-digit royalties based on net sales.
A Chinese Journal of Natural Medicines review describes how AI, especially deep learning, can enhance traditional Chinese medicine network pharmacology, from ingredient identification and network analysis to emerging cell–cell communication networks.